These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 25350768

  • 1. Funding a smoking cessation program for Crohn's disease: an economic evaluation.
    Coward S, Heitman SJ, Clement F, Negron M, Panaccione R, Ghosh S, Barkema HW, Seow C, Leung YP, Kaplan GG.
    Am J Gastroenterol; 2015 Mar; 110(3):368-77. PubMed ID: 25350768
    [Abstract] [Full Text] [Related]

  • 2. Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
    Annemans L, Nackaerts K, Bartsch P, Prignot J, Marbaix S.
    Clin Drug Investig; 2009 Mar; 29(10):655-65. PubMed ID: 19715382
    [Abstract] [Full Text] [Related]

  • 3. Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
    Keating GM, Lyseng-Williamson KA.
    Pharmacoeconomics; 2010 Mar; 28(3):231-54. PubMed ID: 20108995
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
    Lutz MA, Lovato P, Cuesta G.
    Hosp Pract (1995); 2012 Feb; 40(1):24-34. PubMed ID: 22406880
    [Abstract] [Full Text] [Related]

  • 5. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
    Leaviss J, Sullivan W, Ren S, Everson-Hock E, Stevenson M, Stevens JW, Strong M, Cantrell A.
    Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
    Hoogendoorn M, Welsing P, Rutten-van Mölken MP.
    Curr Med Res Opin; 2008 Jan; 24(1):51-61. PubMed ID: 18021492
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
    Lutz MA, Lovato P, Cuesta G.
    Hosp Pract (1995); 2012 Feb; 40(1):35-43. PubMed ID: 22406881
    [Abstract] [Full Text] [Related]

  • 13. A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease.
    Lock K, Wilson K, Murphy D, Riesco JA.
    Expert Opin Pharmacother; 2011 Dec; 12(17):2613-26. PubMed ID: 22017336
    [Abstract] [Full Text] [Related]

  • 14. Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.
    Coleman T, Agboola S, Leonardi-Bee J, Taylor M, McEwen A, McNeill A.
    Health Technol Assess; 2010 Oct; 14(49):1-152, iii-iv. PubMed ID: 21040645
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan.
    Igarashi A, Takuma H, Fukuda T, Tsutani K.
    Pharmacoeconomics; 2009 Oct; 27(3):247-61. PubMed ID: 19354344
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
    Linden K, Jormanainen V, Linna M, Sintonen H, Wilson K, Kotomäki T.
    Curr Med Res Opin; 2010 Mar; 26(3):549-60. PubMed ID: 20050814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.